       Document 0275
 DOCN  M9610275
 TI    Treatment of tuberculosis in developing countries [letter]
 DT    9601
 AU    Elliott AM; Mwinga AG; Foster SD
 SO    Lancet. 1995 Oct 21;346(8982):1098-9. Unique Identifier : AIDSLINE
       MED/96025943
 DE    Antitubercular Agents/*ADVERSE EFFECTS/THERAPEUTIC USE  *Developing
       Countries  Drug Therapy, Combination  Human  HIV
       Seropositivity/*COMPLICATIONS  HIV Seroprevalence  Infant  Tanzania
       Thioacetazone/*ADVERSE EFFECTS  Tuberculosis/*DRUG THERAPY  Zambia
       LETTER  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).

